Product Information
BETAMETHASONE DP 0.05% CRM is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.4646 per GM under NDC 70710123301. Its NADAC has been published 383 times since Jun 5, 2019.
FDA first approved this application on Jan 11, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.5 mg/g
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
70710123301
Classification
Generic
Dosage Form
CREAM
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
BETAMETHASONE DIPROPIONATEApproval Type
Generic (ANDA)
FDA Application
ANDA208885FDA Approved
1/11/2019
TE Code
AB
On Market Since
2/26/2019
Pharmacological Classes
Price Statistics
The NADAC for BETAMETHASONE DP 0.05% CRM has been published 383 times since Jun 5, 2019, and over the history we have for it it has declined 71.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4646 per GM |
|---|---|
| All-time high | $1.7423 (Jul 10, 2019) |
| All-time low | $0.4125 (Nov 20, 2024) |
| 52-week high | $0.6456 |
| 52-week low | $0.4646 |
| Median price | $0.7565 |
| Average price | $0.8621 |
| Largest weekly change | -36.0% (Jul 17, 2024) |
| Weeks tracked | 383 |
| Tracking since | Jun 5, 2019 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 20% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Zydus Pharmaceuticals (USA) Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Betamethasone dipropionate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BETAMETHASONE DP 0.05% CRM?
The current National Average Drug Acquisition Cost (NADAC) for BETAMETHASONE DP 0.05% CRM, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.4646 per GM (NDC 70710123301), effective Sep 30, 2026.
How has the price of BETAMETHASONE DP 0.05% CRM changed over time?
Over the history we have for it, the NADAC for BETAMETHASONE DP 0.05% CRM has declined 71.1%. It has been tracked across 383 weekly CMS publications since Jun 5, 2019.
What are the highest and lowest recorded NADAC prices for BETAMETHASONE DP 0.05% CRM?
Since Jun 5, 2019, the NADAC for BETAMETHASONE DP 0.05% CRM has ranged from a low of $0.4125 (Nov 20, 2024) to a high of $1.7423 (Jul 10, 2019), with a median of $0.7565 per GM.
Are there cheaper alternatives to BETAMETHASONE DP 0.05% CRM?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BETAMETHASONE DP 0.05% CRM, is $0.3711 per GM — about 20% below BETAMETHASONE DP 0.05% CRM.
Who manufactures BETAMETHASONE DP 0.05% CRM?
BETAMETHASONE DP 0.05% CRM (NDC 70710123301) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.